These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 25892185

  • 1. Inhibition of PMCA activity by tau as a function of aging and Alzheimer's neuropathology.
    Berrocal M, Corbacho I, Vázquez-Hernández M, Ávila J, Sepúlveda MR, Mata AM.
    Biochim Biophys Acta; 2015 Jul; 1852(7):1465-76. PubMed ID: 25892185
    [Abstract] [Full Text] [Related]

  • 2. The Plasma Membrane Ca2+-ATPase, a Molecular Target for Tau-induced Cytosolic Calcium Dysregulation.
    Berrocal M, Mata AM.
    Neuroscience; 2023 May 10; 518():112-118. PubMed ID: 35469971
    [Abstract] [Full Text] [Related]

  • 3. Phospholipids and calmodulin modulate the inhibition of PMCA activity by tau.
    Berrocal M, Corbacho I, Sepulveda MR, Gutierrez-Merino C, Mata AM.
    Biochim Biophys Acta Mol Cell Res; 2017 Jun 10; 1864(6):1028-1035. PubMed ID: 27818274
    [Abstract] [Full Text] [Related]

  • 4. Methylene blue activates the PMCA activity and cross-interacts with amyloid β-peptide, blocking Aβ-mediated PMCA inhibition.
    Berrocal M, Corbacho I, Gutierrez-Merino C, Mata AM.
    Neuropharmacology; 2018 Sep 01; 139():163-172. PubMed ID: 30003902
    [Abstract] [Full Text] [Related]

  • 5. Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease.
    Berrocal M, Marcos D, Sepúlveda MR, Pérez M, Avila J, Mata AM.
    FASEB J; 2009 Jun 01; 23(6):1826-34. PubMed ID: 19144698
    [Abstract] [Full Text] [Related]

  • 6. Calmodulin antagonizes amyloid-β peptides-mediated inhibition of brain plasma membrane Ca(2+)-ATPase.
    Berrocal M, Sepulveda MR, Vazquez-Hernandez M, Mata AM.
    Biochim Biophys Acta; 2012 Jun 01; 1822(6):961-9. PubMed ID: 22525477
    [Abstract] [Full Text] [Related]

  • 7. Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity.
    Berrocal M, Saez L, Mata AM.
    Int J Mol Sci; 2021 Jun 03; 22(11):. PubMed ID: 34205207
    [Abstract] [Full Text] [Related]

  • 8. Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function.
    Berrocal M, Caballero-Bermejo M, Gutierrez-Merino C, Mata AM.
    Int J Mol Sci; 2019 Jul 18; 20(14):. PubMed ID: 31323781
    [Abstract] [Full Text] [Related]

  • 9. Functional interplay between plasma membrane Ca2+-ATPase, amyloid β-peptide and tau.
    Mata AM.
    Neurosci Lett; 2018 Jan 10; 663():55-59. PubMed ID: 28780168
    [Abstract] [Full Text] [Related]

  • 10. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part V: why is Ca2+ signal lower in the disease?
    Chen M, Fernandez HL.
    Front Biosci; 1999 Apr 01; 4():A9-15. PubMed ID: 10099137
    [Abstract] [Full Text] [Related]

  • 11. Impairment of the activity of the plasma membrane Ca²⁺-ATPase in Alzheimer's disease.
    Mata AM, Berrocal M, Sepúlveda MR.
    Biochem Soc Trans; 2011 Jun 01; 39(3):819-22. PubMed ID: 21599654
    [Abstract] [Full Text] [Related]

  • 12. The plasma membrane calcium pumps-The old and the new.
    Zaidi A, Adewale M, McLean L, Ramlow P.
    Neurosci Lett; 2018 Jan 10; 663():12-17. PubMed ID: 29452610
    [Abstract] [Full Text] [Related]

  • 13. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
    Schnurra I, Bernstein HG, Riederer P, Braunewell KH.
    Neurobiol Dis; 2001 Oct 10; 8(5):900-9. PubMed ID: 11592857
    [Abstract] [Full Text] [Related]

  • 14. Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.
    Rahman T, Davies DS, Tannenberg RK, Fok S, Shepherd C, Dodd PR, Cullen KM, Goldsbury C.
    J Alzheimers Dis; 2014 Oct 10; 42(4):1443-60. PubMed ID: 25024349
    [Abstract] [Full Text] [Related]

  • 15. The cholinergic system in aging and neuronal degeneration.
    Schliebs R, Arendt T.
    Behav Brain Res; 2011 Aug 10; 221(2):555-63. PubMed ID: 21145918
    [Abstract] [Full Text] [Related]

  • 16. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
    Yu CH, Song GS, Yhee JY, Kim JH, Im KS, Nho WG, Lee JH, Sur JH.
    J Comp Pathol; 2011 Jul 10; 145(1):45-58. PubMed ID: 21256508
    [Abstract] [Full Text] [Related]

  • 17. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
    Lüth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, Münch G.
    Cereb Cortex; 2005 Feb 10; 15(2):211-20. PubMed ID: 15238435
    [Abstract] [Full Text] [Related]

  • 18. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
    Gironès X, Guimerà A, Cruz-Sánchez CZ, Ortega A, Sasaki N, Makita Z, Lafuente JV, Kalaria R, Cruz-Sánchez FF.
    Free Radic Biol Med; 2004 May 15; 36(10):1241-7. PubMed ID: 15110389
    [Abstract] [Full Text] [Related]

  • 19. Amyloid-beta, tau, and dementia.
    Takashima A.
    J Alzheimers Dis; 2009 May 15; 17(4):729-36. PubMed ID: 19542626
    [Abstract] [Full Text] [Related]

  • 20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY.
    Brain Res; 2005 Jan 07; 1031(1):101-8. PubMed ID: 15621017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.